Medifast (MED) Misses Q4 EPS by 2c
Tweet
Share
E-mail
Get Alerts MED Hot Sheet
Price: $12.08 --0%
Revenue Growth %: -24.3%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: -24.3%
Financial Fact:
Provision for income taxes: 2.95M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Medifast (NYSE: MED) reported Q4 EPS of $2.36, $0.02 worse than the analyst estimate of $2.38. Revenue for the quarter came in at $264.9 million versus the consensus estimate of $244.49 million.
For earnings history and earnings-related data on Medifast (MED) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Aytu BioScience (AYTU) Tops Q4 EPS by 28c
- Surf Air Mobility names Palantir veteran as president of SurfOS
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
